Doravirine (MK-1439)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Doravirine (MK-1439), covering 2021-12-02 to 2021-12-02. Get the full timeline:
Most recent: Clinical Trial Update: Evaluating the Pharmacokinetics, Safety, and Tolerability of Doravirine (MK-1439) and Doravirine/Lamivudine/Tenofovir Disoproxil Fumarate (MK-1439A) in HIV-1-Infected Children and Adolescents [Phase 1, Phase 2]